Pieris Pharmaceuticals, Inc. PIRS
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 38961 | 0 | 38961 | 38961 | 0 % | 17/12/2024 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 38961 | 0 | 38961 | 38961 | 0 % | 17/12/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 1125701 | 0 | 1125701 | 1125701 | 9.6 % | 17/12/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 843478 | 0 | 843478 | 843478 | 7.2 % | 17/12/2024 |
| BVF I GP LLC | Delaware | 0 | 843478 | 0 | 843478 | 843478 | 7.2 % | 17/12/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 282223 | 0 | 282223 | 282223 | 2.5 % | 17/12/2024 |
| BVF II GP LLC | Delaware | 0 | 282223 | 0 | 282223 | 282223 | 2.5 % | 17/12/2024 |
| Mark N. Lampert | United States | 0 | 1168117 | 0 | 1168117 | 1168117 | 9.99 % | 17/12/2024 |
| BVF Inc. | Delaware | 0 | 1168117 | 0 | 1168117 | 1168117 | 9.99 % | 17/12/2024 |
| BVF Partners L.P. | Delaware | 0 | 1168117 | 0 | 1168117 | 1168117 | 9.99 % | 17/12/2024 |
| Lynx1 Capital Management LP | Delaware | 0 | 37436 | 0 | 37436 | 37436 | 2.8 % | 14/11/2024 |
| Weston Nichols | United States of America | 0 | 37436 | 0 | 37436 | 37436 | 2.8 % | 14/11/2024 |
| Daniel Schneeberger | Switzerland | 0 | 138641 | 0 | 138641 | 138641 | 10.5 % | 01/08/2024 |
| ADAR1 Capital Management GP, LLC | Texas | 0 | 138641 | 0 | 138641 | 138641 | 10.5 % | 01/08/2024 |
| ADAR1 Capital Management, LLC | Texas | 0 | 138641 | 0 | 138641 | 138641 | 10.5 % | 01/08/2024 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 9312 | 0 | 9312 | 9312 | 0 % | 17/05/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 137592 | 0 | 137592 | 137592 | 10.4 % | 17/05/2024 |
| BVF I GP LLC | Delaware | 0 | 137592 | 0 | 137592 | 137592 | 10.4 % | 17/05/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 107264 | 0 | 107264 | 107264 | 8.1 % | 17/05/2024 |
| BVF II GP LLC | Delaware | 0 | 107264 | 0 | 107264 | 107264 | 8.1 % | 17/05/2024 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 9312 | 0 | 9312 | 9312 | 0 % | 17/05/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 244856 | 0 | 244856 | 244856 | 18.5 % | 17/05/2024 |
| BVF Partners L.P. | Delaware | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| BVF Inc. | Delaware | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| Mark N. Lampert | United States | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 9312 | 0 | 9312 | 9312 | 0 % | 17/05/2024 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 9312 | 0 | 9312 | 9312 | 0 % | 17/05/2024 |
| BVF II GP LLC | Delaware | 0 | 107264 | 0 | 107264 | 107264 | 8.1 % | 17/05/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 107264 | 0 | 107264 | 107264 | 8.1 % | 17/05/2024 |
| BVF I GP LLC | Delaware | 0 | 137592 | 0 | 137592 | 137592 | 10.4 % | 17/05/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 137592 | 0 | 137592 | 137592 | 10.4 % | 17/05/2024 |
| Mark N. Lampert | United States | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| BVF Inc. | Delaware | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| BVF Partners L.P. | Delaware | 0 | 257622 | 0 | 257622 | 257622 | 19.5 % | 17/05/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 244856 | 0 | 244856 | 244856 | 18.5 % | 17/05/2024 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Soleus Capital, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Guy Levy | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Soleus Capital Group, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Soleus Capital, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Guy Levy | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Soleus Capital Group, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 02/02/2024 |
| Sam Huang | United States | 0 | 4938486 | 0 | 4938486 | 4938486 | 6 % | 09/06/2023 |
| Checkpoint Capital Fund, LP | Delaware | 0 | 4938486 | 0 | 4938486 | 4938486 | 6 % | 09/06/2023 |
| Checkpoint Capital, LP | Delaware | 0 | 4938486 | 0 | 4938486 | 4938486 | 6 % | 09/06/2023 |
| Seagen Inc. | Delaware | 3706174 | 0 | 3706174 | 0 | 3706174 | 5 % | 10/02/2023 |
| AstraZeneca PLC | United Kingdom | 3584230 | 0 | 3584230 | 0 | 3584230 | 4.8 % | 10/02/2023 |
| AstraZeneca AB | Sweden | 3584230 | 0 | 3584230 | 0 | 3584230 | 4.8 % | 10/02/2023 |
| Guy Levy | United States | 0 | 4000000 | 0 | 4000000 | 4000000 | 5.4 % | 27/01/2023 |
| Soleus Capital, LLC | Delaware | 0 | 4000000 | 0 | 4000000 | 4000000 | 5.4 % | 27/01/2023 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 4000000 | 0 | 4000000 | 4000000 | 5.4 % | 27/01/2023 |
| Soleus Capital Group, LLC | Delaware | 0 | 4000000 | 0 | 4000000 | 4000000 | 5.4 % | 27/01/2023 |
| Soleus Capital, LLC | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Guy Levy | United States | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Soleus Capital Group, LLC | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Guy Levy | United States | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Soleus Capital Group, LLC | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Soleus Capital, LLC | Delaware | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 1000000 | 0 | 1000000 | 1000000 | 1.3 % | 26/01/2023 |
| Weston Nichols | United States of America | 0 | 3824619 | 0 | 3824619 | 3824619 | 5.1 % | 24/10/2022 |
| Lynx1 Capital Management LP | Delaware | 0 | 3824619 | 0 | 3824619 | 3824619 | 5.1 % | 24/10/2022 |
| Ran Nussbaum | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Tomer Kariv | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Pontifax Management 4 G.P. (2015) Ltd. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Tomer Kariv | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Pontifax 5 G.P. L.P. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Pontifax 5 G.P. L.P. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Ran Nussbaum | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Pontifax Management 4 G.P. (2015) Ltd. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 4.96 % | 14/02/2022 |
| Soleus Capital, LLC | Delaware | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Guy Levy | United States | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Soleus Capital, LLC | Delaware | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Guy Levy | United States | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Soleus Capital Group, LLC | Delaware | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Soleus Capital Group, LLC | Delaware | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| Soleus Capital Master Fund, L.P. | Cayman Islands | 0 | 3884868 | 0 | 3884868 | 3884868 | 5.4 % | 27/01/2022 |
| BlackRock, Inc. | Delaware | 1302450 | 0 | 1302450 | 0 | 1302450 | 2.1 % | 12/07/2021 |
| Citadel Securities GP LLC | Delaware | 0 | 197732 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| Citadel Advisors LLC | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.91 % | 06/07/2021 |
| Citadel Advisors Holdings LP | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.9 % | 06/07/2021 |
| Citadel GP LLC | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.9 % | 06/07/2021 |
| Citadel Securities LLC | Delaware | 0 | 161831 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| CALC IV LP | Delaware | 0 | 197732 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| Citadel Securities GP LLC | Delaware | 0 | 197732 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| Kenneth Griffin | U.S. Citizen | 0 | 3322863 | 0 | 6 | 6 | 5.2 % | 06/07/2021 |
| Citadel Advisors Holdings LP | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.9 % | 06/07/2021 |
| Citadel GP LLC | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.9 % | 06/07/2021 |
| Citadel Securities LLC | Delaware | 0 | 161831 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| CALC IV LP | Delaware | 0 | 197732 | 0 | 6 | 6 | 0.3 % | 06/07/2021 |
| Kenneth Griffin | U.S. Citizen | 0 | 3322863 | 0 | 6 | 6 | 5.2 % | 06/07/2021 |
| Citadel Advisors LLC | Delaware | 0 | 3125131 | 0 | 6 | 6 | 4.91 % | 06/07/2021 |
| AstraZeneca PLC | United Kingdom | 3584230 | 0 | 3584230 | 0 | 3584230 | 5.66 % | 07/04/2021 |
| AstraZeneca AB | Sweden | 3584230 | 0 | 3584230 | 0 | 3584230 | 5.66 % | 07/04/2021 |
| Seagen Inc. | Delaware | 3706174 | 0 | 3706174 | 0 | 3706174 | 6.2 % | 02/04/2021 |
| Marc Schneidman | United States | 0 | 4802291 | 0 | 4802291 | 4802291 | 8.4 % | 16/02/2021 |
| Aquilo Capital, L.P. | Delaware | 0 | 4101019 | 0 | 4101019 | 4101019 | 7.2 % | 16/02/2021 |
| Aquilo Capital Management, LLC | California | 0 | 4802291 | 0 | 4802291 | 4802291 | 8.4 % | 16/02/2021 |
| Marc Schneidman | United States | 0 | 4802291 | 0 | 4802291 | 4802291 | 8.4 % | 16/02/2021 |
| Aquilo Capital, L.P. | Delaware | 0 | 4101019 | 0 | 4101019 | 4101019 | 7.2 % | 16/02/2021 |
| Aquilo Capital Management, LLC | California | 0 | 4802291 | 0 | 4802291 | 4802291 | 8.4 % | 16/02/2021 |
| Pontifax Management 4 G.P. (2015) Ltd. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Ran Nussbaum | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Pontifax 5 G.P. L.P. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Pontifax Management 4 G.P. (2015) Ltd. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Tomer Kariv | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Tomer Kariv | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Ran Nussbaum | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| Pontifax 5 G.P. L.P. | Israel | 0 | 35714281 | 0 | 35714281 | 35714281 | 6.4 % | 16/02/2021 |
| BlackRock, Inc. | Delaware | 3595004 | 0 | 3631309 | 0 | 3631309 | 6.5 % | 29/01/2021 |
| Aquilo Capital, L.P. | Delaware | 0 | 4543848 | 0 | 4543848 | 4543848 | 8.2 % | 21/04/2020 |
| Aquilo Capital Management, LLC | California | 0 | 5575530 | 0 | 5575530 | 5575530 | 10.1 % | 21/04/2020 |
| Marc Schneidman | United States | 0 | 5575530 | 0 | 5575530 | 5575530 | 10.1 % | 21/04/2020 |
| Aquilo Capital Management, LLC | California | 0 | 5575530 | 0 | 5575530 | 5575530 | 10.1 % | 21/04/2020 |
| Aquilo Capital, L.P. | Delaware | 0 | 4543848 | 0 | 4543848 | 4543848 | 8.2 % | 21/04/2020 |
| Marc Schneidman | United States | 0 | 5575530 | 0 | 5575530 | 5575530 | 10.1 % | 21/04/2020 |
| BVF I GP LLC | Delaware | 0 | 2898617 | 0 | 2898617 | 2898617 | 5.3 % | 19/02/2020 |
| Mark N. Lampert | United States | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| BVF Inc. | Delaware | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| BVF Partners L.P. | Delaware | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 5131691 | 0 | 5131691 | 5131691 | 9.3 % | 19/02/2020 |
| BVF Partners L.P. | Delaware | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| BVF Inc. | Delaware | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| Mark N. Lampert | United States | 0 | 5872762 | 0 | 5872762 | 5872762 | 10.7 % | 19/02/2020 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 314139 | 0 | 314139 | 314139 | 0 % | 19/02/2020 |
| BVF II GP LLC | Delaware | 0 | 2233074 | 0 | 2233074 | 2233074 | 4.1 % | 19/02/2020 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 2233074 | 0 | 2233074 | 2233074 | 4.1 % | 19/02/2020 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 2898617 | 0 | 2898617 | 2898617 | 5.3 % | 19/02/2020 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 314139 | 0 | 314139 | 314139 | 0 % | 19/02/2020 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 2898617 | 0 | 2898617 | 2898617 | 5.3 % | 19/02/2020 |
| BVF I GP LLC | Delaware | 0 | 2898617 | 0 | 2898617 | 2898617 | 5.3 % | 19/02/2020 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 2233074 | 0 | 2233074 | 2233074 | 4.1 % | 19/02/2020 |
| BVF II GP LLC | Delaware | 0 | 2233074 | 0 | 2233074 | 2233074 | 4.1 % | 19/02/2020 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 314139 | 0 | 314139 | 314139 | 0 % | 19/02/2020 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 314139 | 0 | 314139 | 314139 | 0 % | 19/02/2020 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 5131691 | 0 | 5131691 | 5131691 | 9.3 % | 19/02/2020 |
| BlackRock, Inc. | Delaware | 3346215 | 0 | 3405125 | 0 | 3405125 | 6.2 % | 07/02/2020 |
| EcoR1 Capital, LLC | Delaware | 0 | 5070424 | 0 | 5070424 | 5070424 | 8.8 % | 14/11/2019 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4220620 | 0 | 4220620 | 4220620 | 7.4 % | 14/11/2019 |
| EcoR1 Capital, LLC | Delaware | 0 | 5070424 | 0 | 5070424 | 5070424 | 8.8 % | 14/11/2019 |
| Oleg Nodelman | United States | 0 | 5070424 | 0 | 5070424 | 5070424 | 8.8 % | 14/11/2019 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4220620 | 0 | 4220620 | 4220620 | 7.4 % | 14/11/2019 |
| Oleg Nodelman | United States | 0 | 5070424 | 0 | 5070424 | 5070424 | 8.8 % | 14/11/2019 |
| Aquilo Capital, L.P. | Delaware | 0 | 2496237 | 0 | 2496237 | 2496237 | 5.1 % | 07/10/2019 |
| Aquilo Capital Management, LLC | California | 0 | 2900436 | 0 | 2900436 | 2900436 | 5.9 % | 07/10/2019 |
| Mr. Marc Schneidman | United States | 0 | 2900436 | 0 | 2900436 | 2900436 | 5.9 % | 07/10/2019 |
| Aquilo Capital, L.P. | Delaware | 0 | 2496237 | 0 | 2496237 | 2496237 | 5.1 % | 07/10/2019 |
| Mr. Marc Schneidman | United States | 0 | 2900436 | 0 | 2900436 | 2900436 | 5.9 % | 07/10/2019 |
| Aquilo Capital Management, LLC | California | 0 | 2900436 | 0 | 2900436 | 2900436 | 5.9 % | 07/10/2019 |
| BVF Inc. | Delaware | 0 | 5626295 | 0 | 5626295 | 5626295 | 10.4 % | 12/07/2018 |
| Mark N. Lampert | United States | 0 | 5626295 | 0 | 5626295 | 5626295 | 10.4 % | 12/07/2018 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 2558773 | 0 | 2558773 | 2558773 | 4.7 % | 12/07/2018 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 2108048 | 0 | 2108048 | 2108048 | 3.9 % | 12/07/2018 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 308720 | 0 | 308720 | 308720 | 0 % | 12/07/2018 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 308720 | 0 | 308720 | 308720 | 0 % | 12/07/2018 |
| BVF Partners L.P. | Delaware | 0 | 5626295 | 0 | 5626295 | 5626295 | 10.4 % | 12/07/2018 |
| Tekla Capital Management LLC | 1962380 | 4.4 % | 12/02/2018 | |||||
| Tekla Capital Management LLC | 1962380 | 4.4 % | 12/02/2018 | |||||
| Daniel R. Omstead | 1962380 | 4.4 % | 12/02/2018 | |||||
| Daniel R. Omstead | 1962380 | 4.4 % | 12/02/2018 | |||||
| Lombard Odier Asset Management (USA) Corp | Delaware | 0 | 2422930 | 0 | 2422930 | 2422930 | 5.63 % | 14/02/2017 |
| Lombard Odier Asset Management (USA) Corp | Delaware | 0 | 2422930 | 0 | 2422930 | 2422930 | 5.63 % | 14/02/2017 |
| Daniel R. Omstead | 4145958 | 9.6 % | 13/02/2017 | |||||
| Tekla Capital Management LLC | 4145958 | 9.6 % | 13/02/2017 | |||||
| Novo Nordisk A/S | The Kingdom of Denmark | 0 | 0 | 0 | 0 | 0 | 0 % | 25/01/2017 |
| BVF Partners L.P. | Delaware | 0 | 4778999 | 0 | 4778999 | 4778999 | 9.99 % | 17/06/2016 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 419000 | 0 | 419000 | 419000 | 0 % | 17/06/2016 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 419000 | 0 | 419000 | 419000 | 0 % | 17/06/2016 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 1401000 | 0 | 1401000 | 1401000 | 2.9 % | 17/06/2016 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1952999 | 0 | 1952999 | 1952999 | 4.1 % | 17/06/2016 |
| BVF Inc. | Delaware | 0 | 4778999 | 0 | 4778999 | 4778999 | 9.99 % | 17/06/2016 |
| Mark N. Lampert | United States | 0 | 4778999 | 0 | 4778999 | 4778999 | 9.99 % | 17/06/2016 |
| Lombard Odier Asset Management (USA) Corp | Delaware | 0 | 2848804 | 0 | 2848804 | 2848804 | 7.17 % | 16/02/2016 |
| Lombard Odier Asset Management (USA) Corp | Delaware | 0 | 2848804 | 0 | 2848804 | 2848804 | 7.17 % | 16/02/2016 |
| Tekla Capital Management LLC | 3848191 | 9.7 % | 12/02/2016 | |||||
| Daniel R. Omstead | 3848191 | 9.7 % | 12/02/2016 | |||||
| Novo Nordisk A/S | The Kingdom of Denmark | 2051802 | 0 | 2051802 | 0 | 2051802 | 5.2 % | 28/01/2016 |
| Mark N. Tompkins | Canada | 1958912 | 0 | 1958912 | 0 | 1958912 | 4.9 % | 24/11/2015 |
| Richard Lim | United States of America | 0 | 2483949 | 0 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Otello Stampacchia | Italy | 0 | 2483949 | 0 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Paster | United States of America | 0 | 2483949 | 0 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Omega Fund IV G.P. Manager, Ltd. | Cayman Islands | 2483949 | 2483949 | 2483949 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Global Life Bioventure IV, S.à r.l. | Luxembourg | 2483949 | 2483949 | 2483949 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Omega Fund IV, L.P. | Cayman Islands | 2483949 | 2483949 | 2483949 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Omega Fund IV GP, L.P. | Cayman Islands | 2483949 | 2483949 | 2483949 | 2483949 | 2483949 | 6.25 % | 11/09/2015 |
| Mark N. Tompkins | Canada | 2176864 | 0 | 2176864 | 0 | 2176864 | 5.6 % | 10/07/2015 |